VK2735

· Viking Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VK2735, covering 2025-02-12 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) [Phase 3]